US Stock MarketDetailed Quotes

EBS Emergent BioSolutions

Watchlist
  • 5.500
  • -0.230-4.01%
Close Mar 25 16:00 ET
  • 5.501
  • +0.001+0.01%
Post 20:01 ET
298.85MMarket Cap-1.53P/E (TTM)
Full Hours
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

Comments

    $Emergent BioSolutions (EBS.US)$
    Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg
    Thursday, 20th March at 8:06 am
    LONDON and GAITHERSBURG, Md., March 20, 2025 (GLOBE NEWSWIRE) -- Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, announces the approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg, by Health Canada for the treatment of known or suspected opioid overdose, as manifested by respiratory and/or central ner...
    2
    $Emergent BioSolutions (EBS.US)$
    Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International
    Wednesday, 19th March at 4:30 pm
    GAITHERSBURG, Md., March 19, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has completed the sale of its Baltimore-Bayview drug substance manufacturing facility to Syngene International. Emergent received approximately $36.5 million at closing, which is subject to customary post-closing...
    $Emergent BioSolutions (EBS.US)$ Reuters· just1min
    Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers With Five Critical Medical Countermeasure Products
    $Emergent BioSolutions (EBS.US)$
    to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs
    Thursday, 13th March at 8:29 am
    NYC Building & Construction Industry Safety Fund program will equip local workers, contractors and staff with NARCAN® Nasal Spray and provide trainings on how to administer the life-saving medicine
    Leading mental health and addiction treatment services provider, Pathway Healthcare, breaks down stigma and access ...
    $Emergent BioSolutions (EBS.US)$ Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs
    2 MINUTES AGO, 8:29 AM EDT
    VIA GLOBENEWSWIRE
    NYC Building & Construction Industry Safety Fund program will equip local workers, contractors and staff with NARCAN® Nasal Spray and provide trainings on how to administer the life-saving medicine
    Leading mental health and addiction treatment services p...
Read more
Market Insights
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.